Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study
David J. Pinato(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Yien Ning Sophia Wong(CRUK Lung Cancer Centre of Excellence), M. Carmen Carmona-García(München Klinik), E. Colomba-Blameble(Institut Gustave Roussy), Lorenza Scotti(University of Milano-Bicocca), Joanne Evans, Eudald Felip(University of Ioannina), Christopher C.T. Sng(University College Hospital), Daniele Generali(University of Trieste), Salvatore Grisanti(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Rachel Sharkey(Chelsea and Westminster Hospital), Diego Ottaviani(Royal London Hospital), John Chester(Velindre Cancer Centre), Ariadna Roqué(Institut Català d'Oncologia), N. Saoudi Gonzalez, Valeria Tovazzi(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Andrea Marrari(IRCCS Humanitas Research Hospital), Alberto Zambelli, Rachel Wuerstlein(LMU Klinikum), Alexia Bertuzzi(Humanitas University), Ramón Salazar(Institut Català d'Oncologia), Vittoria Fotia(Ospedale Papa Giovanni XXIII), Ailsa Sita-Lumsden(Guy's and St Thomas' NHS Foundation Trust), Ricard Mesı́a(Institut d'Investigació Biomédica de Bellvitge), Thomas Newsom-Davis(Chelsea and Westminster Hospital), David García-Illescas(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Rossella Bertulli(Fondazione IRCCS Istituto Nazionale dei Tumori), Alessandra Gennari(Ente Ospedaliero Ospedali Galliera), Carlo Tondini(Ospedale Papa Giovanni XXIII), Saoirse Dolly(Guy's and St Thomas' NHS Foundation Trust), Uma Mukherjee(University College London Hospitals NHS Foundation Trust), Joan Brunet(Institut Català d'Ornitologia), Johann Colomba(Guy's and St Thomas' NHS Foundation Trust), Charlotte Moss(Southampton General Hospital), Mark Bower(Chelsea and Westminster Hospital), Federica Biello(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Oriol Mirallas(Hebron University), Bruno Vincenzi(Campus Bio Medico University Hospital), Fanny Pommeret(Université Paris-Saclay), Alvin Lee(Duke Medical Center), Angela Loizidou(Université Libre de Bruxelles), Beth Russell(King's College London), Chris Chung(Hammersmith Hospital), Roxana Reyes(Hospital Clínic de Barcelona), Elia Seguí, Michela Libertini(Fondazione Poliambulanza Istituto Ospedaliero), Claudia Andrea Cruz(Ospedale Papa Giovanni XXIII), Gianpiero Rizzo(Policlinico San Matteo Fondazione), Raquel Liñan(Institut Català d'Oncologia), Myria Galazi(Bank of Cyprus Oncology Center)
Cited by 51
Related Papers
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
Gastroenteropancreatic neuroendocrine tumours
|The Lancet Oncology|2008|1.8k
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
|Annals of Oncology|2021|1.4k
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2020|1.3k